Targeting Predialysis Glucose up to 180 mg/dl Reduces Glycemic Variability in End Stage Diabetic Nephropathy

CONTEXT: Glycemic variability plays a major role in the development as well as the progression of cardiovascular disease in diabetes. AIMS: We compared the mean plasma glucose and glycemic variability (GV) parameters on and off hemodialysis (HD) in patients with End-Stage Diabetic Nephropathy (ESDN)...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Nikita, Gada, Jugal V., Billa, Vishwanath S., Kothari, Jatin Piyush, Bichu, Shrirang D., Usulumarty, Deepa H., Khaire, Suhas S., Varthakavi, Premlata K., Bhagwat, Nikhil M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815189/
https://www.ncbi.nlm.nih.gov/pubmed/36618515
http://dx.doi.org/10.4103/ijem.ijem_157_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815189/
https://www.ncbi.nlm.nih.gov/pubmed/36618515
http://dx.doi.org/10.4103/ijem.ijem_157_22

Ejemplares similares